AU2001294771A1 - High-throughput assays for the proteolytic activities of clostridial neurotoxins - Google Patents

High-throughput assays for the proteolytic activities of clostridial neurotoxins

Info

Publication number
AU2001294771A1
AU2001294771A1 AU2001294771A AU9477101A AU2001294771A1 AU 2001294771 A1 AU2001294771 A1 AU 2001294771A1 AU 2001294771 A AU2001294771 A AU 2001294771A AU 9477101 A AU9477101 A AU 9477101A AU 2001294771 A1 AU2001294771 A1 AU 2001294771A1
Authority
AU
Australia
Prior art keywords
proteolytic activities
substrates
assays
clostridial neurotoxins
throughput assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294771A
Other languages
English (en)
Inventor
James J. Schmidt
Robert G. Stafford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Medical Research Institute of Infectious Diseases
Original Assignee
U S MEDICAL RES INST OF INFECT
US Medical Research Institute of Infectious Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U S MEDICAL RES INST OF INFECT, US Medical Research Institute of Infectious Diseases filed Critical U S MEDICAL RES INST OF INFECT
Publication of AU2001294771A1 publication Critical patent/AU2001294771A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/842—Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001294771A 2000-09-25 2001-09-25 High-throughput assays for the proteolytic activities of clostridial neurotoxins Abandoned AU2001294771A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23505000P 2000-09-25 2000-09-25
US60/235,050 2000-09-25
PCT/US2001/030188 WO2002025284A2 (fr) 2000-09-25 2001-09-25 Tests de detection rapide des activites proteolytiques des neurotoxines clostridiales

Publications (1)

Publication Number Publication Date
AU2001294771A1 true AU2001294771A1 (en) 2002-04-02

Family

ID=22883879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294771A Abandoned AU2001294771A1 (en) 2000-09-25 2001-09-25 High-throughput assays for the proteolytic activities of clostridial neurotoxins

Country Status (7)

Country Link
US (3) US6762280B2 (fr)
EP (1) EP1419390B1 (fr)
AT (1) ATE378596T1 (fr)
AU (1) AU2001294771A1 (fr)
CA (1) CA2451909C (fr)
DE (1) DE60131468D1 (fr)
WO (1) WO2002025284A2 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563874B2 (en) * 1998-08-31 2009-07-21 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
DE60131468D1 (de) * 2000-09-25 2007-12-27 U S Medical Res Inst Of Infect Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen
US8148141B2 (en) * 2001-05-07 2012-04-03 Hipep Laboratories Peptide-immobilized substrate and method for measuring target protein
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7332567B2 (en) 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
AU2003272800A1 (en) * 2002-10-01 2004-04-23 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
WO2004052934A1 (fr) * 2002-12-12 2004-06-24 National Institute Of Advanced Industrial Science And Technology Proteine de surveillance destinee a mesurer le traitement d'une proteine
WO2004102215A1 (fr) * 2003-05-07 2004-11-25 The United States Of America, As Represented By The Secretary Of The Navy Naval Research Laboratory Analyse de l'efficacite de vaccins a base de neurotoxine
US20050079566A1 (en) * 2003-09-10 2005-04-14 Caterer Nigel Robert Analytical methods for determination of proteolytic cleavage at specific sites
US7611856B2 (en) * 2003-11-05 2009-11-03 Los Alamos National Security, Llc Mass spectrometry-based methods for detection and differentiation of botulinum neurotoxins
US8137924B2 (en) 2003-12-19 2012-03-20 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
US7700738B2 (en) * 2005-01-27 2010-04-20 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
ES2345506T3 (es) 2005-04-05 2010-09-24 Allergan, Inc. Ensayos de fret a base de colorantes lipofilos para determinar la actividad de la toxina clostridial.
ES2351942T3 (es) 2005-04-05 2011-02-14 Allergan Inc Analisis de la actividad de una toxina clostridial.
CA2610103A1 (fr) 2005-09-19 2007-03-19 Allergan, Inc. Toxines clostridiales activables par toxines clostridiales
DE102006019447A1 (de) * 2006-04-24 2007-10-25 Dressler, Dirk, Dr. Markierung von Botulinum Toxin
CA2651917A1 (fr) * 2006-06-09 2007-12-13 Bio Pur Ag Procede pour la detection de reactions enzymatiques
CA2680741A1 (fr) 2007-03-22 2009-01-15 The Regents Of The University Of California Anticorps monoclonaux therapeutiques qui neutralisent les neurotoxines botuliniques
US8067192B2 (en) * 2007-06-05 2011-11-29 City Of Hope Methods for detection of botulinum neurotoxin
US8753831B2 (en) * 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
US20110098309A1 (en) * 2007-07-12 2011-04-28 Acumen Pharmaceuticals, Inc. Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds
US9006283B2 (en) 2007-07-12 2015-04-14 Acumen Pharmaceuticals, Inc. Methods of modifying amyloid β oligomers using non-peptidic compounds
US8962677B2 (en) * 2007-07-12 2015-02-24 Acumen Pharmaceuticals, Inc. Methods of restoring cognitive ability using non-peptidic compounds
US9217024B2 (en) 2007-12-18 2015-12-22 Acumen Pharmaceuticals, Inc. ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
US9000131B2 (en) 2008-07-31 2015-04-07 The Regents Of The University Of California Antibodies that neutralize botulinum neurotoxins
US20120202754A1 (en) * 2009-10-18 2012-08-09 Schmidt James J Enhanced substrates for the protease activity of serotype a botulinum neurotoxin
US9243057B2 (en) 2010-08-31 2016-01-26 The Regents Of The University Of California Antibodies for botulinum neurotoxins
RU2549463C1 (ru) * 2013-12-03 2015-04-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ определения ботулинического нейротоксина типа а на основе иммунодетекции, сопряженной с полимеразной цепной реакцией
US11293927B2 (en) 2018-04-30 2022-04-05 Ribon Therapeutics, Inc. Screening methods for PARP modulators
IL272002A (en) * 2020-01-13 2021-07-29 The Israel Institute Of Biological Res Iibr Methods for identifying active compounds against Clostridium neurotoxin
CN114539362B (zh) * 2022-04-25 2022-07-26 中国疾病预防控制中心传染病预防控制所 一种肉毒毒素特异性底物肽、检测试剂盒和检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
US5605809A (en) * 1994-10-28 1997-02-25 Oncoimmunin, Inc. Compositions for the detection of proteases in biological samples and methods of use thereof
US5965699A (en) * 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
FR2809733B1 (fr) 2000-06-02 2004-04-30 Inst Nat Sante Rech Med Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
DE60131468D1 (de) * 2000-09-25 2007-12-27 U S Medical Res Inst Of Infect Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen

Also Published As

Publication number Publication date
US20040146963A1 (en) 2004-07-29
ATE378596T1 (de) 2007-11-15
WO2002025284A3 (fr) 2003-09-18
US7157553B2 (en) 2007-01-02
DE60131468D1 (de) 2007-12-27
EP1419390B1 (fr) 2007-11-14
US20050287622A1 (en) 2005-12-29
EP1419390A2 (fr) 2004-05-19
CA2451909C (fr) 2010-12-21
US20030077685A1 (en) 2003-04-24
CA2451909A1 (fr) 2002-03-28
US7034107B2 (en) 2006-04-25
US6762280B2 (en) 2004-07-13
WO2002025284A2 (fr) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001294771A1 (en) High-throughput assays for the proteolytic activities of clostridial neurotoxins
WO2003022028A3 (fr) Methodes, reactifs, kits et appareil d'analyse de fonction proteique
Dean et al. A green fluorescent chemosensor for amino acids provides a versatile high-throughput screening (HTS) assay for proteases
KR940019867A (ko) 내독소 검정용 반응제 및 이를 사용하는 내독소 검정방법
AU2001251291A1 (en) Ubiquitin ligase assay
NO941781L (no) Ikke-radioaktiv immunanalyse
GB1520261A (en) Tripeptides containing proline and the use thereof in the quantitative determination of enzymes
Cigić et al. Location of the binding site for chloride ion activation of cathepsin C
Lainé et al. Simultaneous kinetic determinations of lipase, chymotrypsin, trypsin, elastase, and amylase on the same microtiter plate
EP1111385A3 (fr) Complexe d'une enzyme et une protéine
AU4597599A (en) Device and method for the determination of protein domain boundaries
Hilpert et al. Characterizing and optimizing protease/peptide inhibitor interactions, a new application for spot synthesis
WO2003016904A3 (fr) Etiquettes de sequence peptidique et leur procede d'utilisation
AU2001296830A1 (en) Ligand based solution assay for low concentration analytes
Marokhazi et al. Cleavage site analysis of a serralysin‐like protease, PrtA, from an insect pathogen Photorhabdus luminescens and development of a highly sensitive and specific substrate
AU5381086A (en) Fluorescence polarization assay for amylase
Yamaguchi et al. Specificity and molecular properties of penicillolysin, a metalloproteinase from Penicillium citrinum
Wildeboer et al. Characterization of bacterial proteases with a panel of fluorescent peptide substrates
WO2010090756A2 (fr) Dosages fret, procédés de mise en oeuvre desdits dosages et composés utilisables dans le cadre desdits dosages
AU5178698A (en) Novel serine protease inhibitor nucleic acid molecules, proteins and uses hereof
Berry et al. Bacterial collagenase and collagen identification
EP1980616A3 (fr) Protéine STCE se liant à l'inhibiteur d'esterase d'E. coli 0157:H7 C1 et ses utilisations
Šafařík et al. Isolation and removal of proteolytic enzymes with magnetic cross-linked erythrocytes
Müller et al. Assay of diverse protease activities on the basis of a small synthetic substrate
AU2003203028A1 (en) Aggrecanase-1 and -2 peptide substrates and methods